Received: 20 December 2018
Revised: 30 January 2019
Accepted: 11 February 2019
First Online: 6 March 2019
Ethics approval and consent to participate
: DS is an unpaid consultant and has an equity interest in Northern Therapeutics (Montréal, QC, Canada). The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.